Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study

OBJECTIVES: The pan-European BENEFIT study of patients with stable rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) who transitioned from reference etanercept to SB4 found no clinically meaningful changes in disease control after transition. The analysis aims to illustrate the peculiarit...

Descripción completa

Detalles Bibliográficos
Autores principales: Luciano, Nicoletta, Fusaro, Enrico, Ditto, Maria Chiara, Ianniello, Aurora, Bellis, Emanuela, Bruni, Cosimo, Viapiana, Ombretta, Gremese, Elisa, Migliore, Alberto, Romoli, Ester, Conforti, Ludovica, Govoni, Marcello, Matucci-Cerinic, Marco, Selmi, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524806/
https://www.ncbi.nlm.nih.gov/pubmed/36467021
http://dx.doi.org/10.2478/rir-2022-0005

Ejemplares similares

Ejemplares similares